To help seal the deal financially and repay existing borrowings, KKR and Veritas are reportedly in talks for debt of $5 billion to $6 billion with both Wall Street banks and private credit funds, the publication reported. If approved, this could make the direct loan the largest on record.
The two firms are seeking a private loan featuring a “payment-in-kind” structure, allowing for interest with more debt on the entire financing to be paid by KKR, according to Bloomberg. This is Veritas’ second attempt to sell part of Cotiviti this year, after talks with the Carlyle Group ended for a planned $15 billion buyout April 12.
Discussions between the two firms come as the Justice Department, Federal Trade Commission and HHS plan to conduct a federal inquiry into “corporate greed in healthcare.” The goal of the inquiry is to understand how private equity and corporations are affecting healthcare access and cost, with the information collected eventually planned for aiding the development of future regulations and enforcement prioritization.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
